No Detail Found!

Diagnostic approaches and prevalence of Rifampicin resistant Mycobacterium tuberculosis in district Mardan

Author(s)
Atif Kamil Department of Biotechnology, Abdul Wali Khan University Mardan, KPK, Pakistan
Haseeb Ullah Department of Biotechnology, Abdul Wali Khan University Mardan, KPK, Pakistan; King Mongkut’s University of Technology, Thonburi, Thailand
Farooq Hussain Department of Physical Education and Sports, Abdul Wali Khan University Mardan, KPK, Pakistan
Muhsin Jamal Department of Microbiology, Abdul Wali Khan University Mardan, KPK, Pakistan
Azmat Ali Department of Physical Education and Sports, Abdul Wali Khan University Mardan, KPK, Pakistan
Muhammad Shah Department of Physical Education and Sports, Abdul Wali Khan University Mardan, KPK, Pakistan
Ayaz Ahmad Department of Biotechnology, Abdul Wali Khan University Mardan, KPK, Pakistan
Jawad Khan Department of Biotechnology, Abdul Wali Khan University Mardan, KPK, Pakistan
Faheem Anwar Department of Biotechnology, Abdul Wali Khan University Mardan, KPK, Pakistan
Nabila Department of Plant Sciences, Quaid-i-e Azam University Islamabad, Pakistan
Abstract
The disease tuberculosis (TB) caused by Mycobacterium Tuberculosis (MTB) is most common infectious disease in developing countries. The disease is fatal if not treated during the early stages of infection, thereby early and precise detection is a decisive step in curing the disease. The aim of this study was to analyze the prevalence of tuberculosis in patients reporting to Mardan Medical Complex (MMC), located in the district Mardan, KPK, Pakistan. The sputum of patients was analysed by Ziehl-Nilsen (ZN) staining technique followed by light microscopy called Acid-Fast Bacillus (AFB) staining. The sputum samples were collected from the patients and analysed by special PCR method called GeneXpert MTB/RIF assay, for genomic detection and resistance assay for rifampicin antibiotic were used, are the commonly used medicine for the treatment of MTB infection. Total 121 patients reported to MMC, represented 74 % patients from Mardan, 12% from Nowshera and 14% from Swabi. These patients were screened for the aim to evaluate the techniques for the detection of MTB. The light microscopy method confirmed 66 (55%) of the patients positive for MTB, whereas the same samples reported 78 (68%) patients positive for MTB through GeneXpert MTB/RIF assay, The Positive Predictive Value (PPV) and Negative Predictive Value (NPV) found for light microscopy were 99% and 78.1% respectively. The most used drug rifampicin was found ineffective in 9 patients (7%). Additionally, 83% of the patients when interviewed had a folk history of tuberculosis.
Publication Details
Page(s) 65-72
Published Journal: Abasyn Journal of Life Sciences, Volume: 4, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
PCR, Mycobacterium tuberculosis, rifampicin, Microscopy
References
Achtman M. .2008 .Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annual review of microbiology, : .
Bassili A.,Seita A.,Baghdadi S.,AlAbsi A.,Abdilai I.,Agboatwalla M.,Enarson D. A. Diagnostic .2008 .and treatment delay in tuberculosis in 7 countries of the Eastern Mediterranean Region. Infectious Diseases in Clinical Practice, (1) : 23-35.
Rook G. A.,Bloom B. R. . .Mechanisms of pathogenesis in tuberculosis. , 1994 : 485-501.
Boehme C. C.,Nabeta P.,Hillemann D.,Nicol M. P.,Shenai S.,Krapp F.,Perkins F. .2010 .Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine, (11) : 1005-1015.
Casemore D. P.,Armstrong M.,Sands R. L. .1985 .Laboratory diagnosis of cryptosporidiosis. Journal of Clinical Pathology, (12) : 1337-1341.
.2006 .Promising drugs against tuberculosis. Recent Patents on Anti-Infective Drug Discovery, (1) : 33-44.
Gilani S. I.,Khurram M. . .Perception of tuberculosis in Pakistan: findings of a nation-wide survey. Age (Years) 2012, 30(965) : 35.
Govender V. S.,Ramsugit S.,Pillay M. .2014 .Mycobacterium tuberculosis adhesins: potential biomarkers as anti-tuberculosis therapeutic and diagnostic targets. Microbiology, (9) : 1821-1831.
Hobby G. L.,Lenert T. F. .1968 .The antimycobacterial activity of rifampin. American Review of Respiratory Disease, (4) : 713-714.
Horsburgh C. R. .2004 .Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine, (20) : 2060-2067.
Jasmer R. M.,Nahid P.,Hopewell P. .2002 .Latent tuberculosis infection. New England Journal of Medicine, (23) : 1860-1866.
Laifangbam S.,Singh H. L.,Singh N. B.,Devi K. M.,Singh N. T. .2009 .A comparative study of fluorescent microscopy with Ziehl-Neelsen staining and culture for the diagnosis of pulmonary tuberculosis. KathmanduUniversity Medical Journal, (3) : 226-230.
Maggi N.,Arioli V.,Sensi P.,Rifamycins P. . .NSubstituted Aminomethyl Derivatives of Rifamycin SV2. Journal of medicinal chemistry, 1965, 8(6) : 790-793.
Marlowe E. M.,Novak-Weekley S. M.,Cumpio J.,Sharp S. E.,Momeny M. A.,Babst A.,Pandori M. .2011 .Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. Journal of clinical microbiology, (4) : 1621-1623.
Murray C. J. L.,Salomon J. A. .1998 .Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding [. The Pittsfield Lecture]. The International Journal of Tuberculosis and Lung Disease, (9) : S9-S15.
Pai M.,Kalantri S.,Dheda K. . .New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert review of molecular diagnostics, 2006, 6(3) : 423-432.
Sensi P. . .History of the development of rifampin. Reviews of infectious diseases, 5(Supplement_3), : S402-S406.
Shet A. .2012 .Tuberculosis in the days of yore. Pediatric Infectious Disease, (2) : 43-44.
0

Citations

0

Downloads

55

Views